• SEC 10-K Annual Financial Filing. Contains sales figures and patent expiration dates for the company's ten largest selling drugs, firm-level R&D figures, information on lawsuits filed against the firm, income and cost data, stock information, financial holdings, and a complete list of Pfizer's subsidiaries.
• Notice of 2000 Annual Meeting and Proxy Statement. Contains exececutive compensation figures, including salaries and stock options.
• CEO William C. Steere Jr.'s salary and stock options from the AFL-CIO's page on executive compensation.

• Soft Money Donations in the 1999-2000 Election Cycle Source: Center for Responsive Politics, www.opensecrets.org
• PAC Contributions to Federal Candidates in the 1999-2000 Election Cycle Source: Center for Responsive Politics, www.opensecrets.org
• Lobbying Expenditures in 1998 Source: Center for Responsive Politics, www.opensecrets.org

Viagra

• June 13, 2001. Gauri Kamath for the Economic Times. Pfizer obtains injunction against Cadila on Penegra.
• November 8, 2000. Pfizer loses Viagra patent in the UK.
• See below for information on Pfizer's efforts to get Viagra purchases subsidized by the Australian government.

Fluconazole

• CPT page on Fluconazole
• Treatment Acces Campaign's (TAC) page on Fluconazole. Information on this group's efforts to make fluconazole available in South Africa.
• June 6, 2001, Pfizer Press Release. Pfizer to Offer Diflucan Antifungal Medicine at No Charge To HIV/AIDS Patients in 50 Least Developed Countries Around the World.
• December 19, 2000. Letter from Cipla to Pfizer requesting a voluntary, non-exclusive license to produce sell generic fluconasole in developing nations. Cipla offers to pay royalties of up to five percent.
• December 16, 2000. Carmen Perez-Casas, Pierre Chirac, Daniel Berman, Nathan Ford in the Lancet, Volume 356, Number 9247. Access to fluconazole in less-developed countries

Australia

Summary: The Australian government subsidizes the purchase of a number of drugs, which highly influences the national sales of those drugs. In order for sales of a certain drug to be subsidized, that drug must be listed on the government's Pharmaceutical Benefits Scheme (PBS). Pfizer has been lobbying hard to get its blockbuster drug, Viagra, included in the PBS, leading to the dismissal of advisors who recommended against Viagra's inclusion. (For more info on the Australian Viagra controversy, see CPT's page on Australia.

• December 2, 2000. Row Over Drug Panel Shake-Up Australian Financial Review story by Ray Moynihan.
• December 2, 2000. Drug giant admits world concern at Australian prices. Sydney Morning Herald story by Mark Metherell and Julie Robotham.
• December 2, 2000. Manufacturers frustrated by the subsidy system. Sydney Morning Herald story by Mark Metherell.
• December 2, 2000. Guardians on shaky ground. Sydney Morning Herald story by Paul Sheehan.
• December 2, 2000. Howard Ahdeah, So Far. Sydney Morning Herald editorial.
• December 1, 2000. Doctors call for inquiry into drug-subsidy reform plans. AAP story published on theage.com.

• January 16, 2001. Doctors Say Drug Trial's Approval Was Backdated. Washington Post story by Joe Stephens.
• January 13, 2001. The Lancet, 357, 9250. Nigerian government investigates Pfizer drug trial allegations.
• December 17, 2000. As Drug Testing Spreads, Profits and Lives Hang In the Balance. Washington Post story by Joe Stephens.
• December 17, 2000. Pfizer Statement on Washington Post Clinical Trial Series of which the above article is a part. Contains a link to the actual correspondence between Pfizer and the Post.

Summary: Pfizer sued a Philippine government-owned company (PITC, Philippine International Trading Corporation), the Philippines FDA (BFAD, Bureau of Food and Drugs) and two government offcials (in their personal capacity). For importing from India samples of amlodipine besylate (Norvasc), that Pfizer sells in both the Philippines and India, and for submitting the samples to the government drug regulatory agency. The main issue is the early working of a patent (so called, Bolar exception). (For more info on the Philippines Norvasc controversy, see CPT's page on The Philippines.

• Text of the Complaint in Pfizer's Lawsuit.
• April 1, 2006. James Love in the Huffington Post. Terrorism, Pfizer Style.
• March 31, 2006. Judit Rius Sanjuan. SecondView. Pfizer is suing Philippine’s governmental officials in their personal capacity in order to stop parallel trade.

Philanthropy

• October 4, 2002. Pfizer press release. Pfizer Joins United Nations Global Compact, Endorses Principles on Environment, Labor and Human Rights.
• January 16, 2002. Robert Pear and Melody Petersen for the New York Times. Pfizer to Offer Drug Discount to Low-Income Elderly.
  Pfizer documents
  • June 11, 2001, Pfizer Press Release. African and Western Alliance to Build First Large-Scale AIDS Medical Training Facility in Africa.
  • June 6, 2001, Pfizer Press Release. Pfizer to Offer Diflucan Antifungal Medicine at No Charge To HIV/AIDS Patients in 50 Least Developed Countries Around the World.
  • Minds In Motion.
  • International Trachoma Initiative.
  News Stories
  • June 11, 2001. Karl Vick in Washington Post. Pfizer to Help Africa Fight HIV
  • June 11, 2001. Inter Press Service. Pfizer Puts 'Life Before Profit' with New AIDS Clinic.

• April 24, 2003. Sarah Boseley and Nils Pratley for the Guardian. In the time it takes you to read this article Pfizer will make $250,000. So does it have a duty to provide cheap drugs to the poor?
• January 22, 2003. Joe Richter for Bloomberg. Pfizer CEO Must Keep Seeking Deals.
• January 9, 2002. Scott Hensley and Chris Adams for the Wall Street Journal. Pfizer Confirms It Received a Subpoena From the GAO Seeking Drug-Price Data.
• July 19, 2001. Oxfam Press Release. Pfizer: The industry leader in pricing drugs beyond the reach of the poor in developing countries.

MAIN NUMBER
235 East 42nd Street
New York, NY 10017
(tel)212-573-2323

WASHINGTON, DC OFFICE
325 7th St NW
Washington, DC
(tel)202-783-7070
(fax)202-347-2044
M. Kenneth Bowler, V.P.
Federal Government Relations